These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18331333)

  • 21. Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy.
    Page SM; Brownlee GG
    Gene Ther; 1998 Mar; 5(3):394-402. PubMed ID: 9614560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between age and the secretions of melanocyte-stimulating cytokines in cultured keratinocytes and fibroblasts.
    Okazaki M; Yoshimura K; Uchida G; Harii K
    Br J Dermatol; 2005 Dec; 153 Suppl 2():23-9. PubMed ID: 16280018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human skin keratinocytes modified by a Friend-derived retroviral vector: a functional approach.
    Arango M; Chamorro C; Cohen-Haguenauer O; Rojas M; Restrepo LM
    Dermatol Online J; 2005 Aug; 11(2):2. PubMed ID: 16150210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organoids direct systemic expression of erythropoietin in mice.
    Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ
    Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin-targeted gene transfer using in vivo electroporation.
    Maruyama H; Ataka K; Higuchi N; Sakamoto F; Gejyo F; Miyazaki J
    Gene Ther; 2001 Dec; 8(23):1808-12. PubMed ID: 11803401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivering erythropoietin through genetically engineered cells.
    Bohl D; Heard JM
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S159-62. PubMed ID: 11065350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained gene expression in transplanted skin fibroblasts in rats.
    Wei MQ; Lejnieks DV; Ramesh N; Lau S; Seppen J; Osborne WR
    Gene Ther; 1999 May; 6(5):840-4. PubMed ID: 10505109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient hyperproliferation of a transgenic human epidermis expressing hepatocyte growth factor.
    Hamoen KE; Morgan JR
    Cell Transplant; 2002; 11(4):385-95. PubMed ID: 12162379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopump: Autologous skin-derived micro-organ genetically engineered to provide sustained continuous secretion of therapeutic proteins.
    Mitrani E; Pearlman A; Stern B; Miari R; Goltsman H; Kunicher N; Panet A
    Dermatol Ther; 2011; 24(5):489-97. PubMed ID: 22353155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis.
    Wang R; Zou Y; Yuan Z; Wang Y; Chen Y; Mao Y; Zhu ZA; Li H; Tang X; Lu J; Yi J
    Anat Rec (Hoboken); 2009 Jun; 292(6):777-86. PubMed ID: 19462444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifications of the fibroblast growth factor-2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor-2 protein.
    Chen ST; Gysin R; Kapur S; Baylink DJ; Lau KH
    J Cell Biochem; 2007 Apr; 100(6):1493-508. PubMed ID: 17243099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction.
    Agrawal N; You H; Liu Y; Chiriva-Internati M; Bremner J; Garg T; Grizzi F; Krishna Prasad C; Mehta JL; Hermonat PL
    Tissue Eng; 2004; 10(11-12):1707-15. PubMed ID: 15684679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrated keratinocytes reduce collagen synthesis by fibroblasts via paracrine mechanisms.
    Tandara AA; Kloeters O; Mogford JE; Mustoe TA
    Wound Repair Regen; 2007; 15(4):497-504. PubMed ID: 17650093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient retroviral gene transfer to epidermal stem cells.
    Lei P; Andreadis ST
    Methods Mol Biol; 2008; 433():367-79. PubMed ID: 18679635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates.
    Fattori E; Cappelletti M; Zampaglione I; Mennuni C; Calvaruso F; Arcuri M; Rizzuto G; Costa P; Perretta G; Ciliberto G; La Monica N
    J Gene Med; 2005 Feb; 7(2):228-36. PubMed ID: 15515133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance P receptor expression in human skin keratinocytes and fibroblasts.
    Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
    Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.